Commercialisation director joins Edinburgh BioQuarter
Life sciences entrepreneur Michael Capaldi joins Scotland\'s flagship project
Capaldi will lead a team of up to 15 people to progress a £12m commercialisation project that will bridge the gap between industry and research.
Capaldi has more than 26 years’ experience in the pharmaceutical and life sciences industries within the UK, Europe and the US.
You may also like
Research & Development
Nuclera and University of Cambridge researchers demonstrate rapid structural analysis of challenging drug target
Collaboration combines cell-free protein synthesis, proprietary nanodisc technology and cryo-electron microscopy (cryo-EM) for high-resolution structural analysis of a G protein-coupled receptor (GPCR)
Research & Development
Evotec secures $2.9m grant to advance stem cell-based drug safety testing
The three-year Gates Foundation grant will support Evotec's human induced pluripotent stem cell platform, helping global health researchers identify potential developmental toxicity risks earlier in drug discovery
Research & Development
TUM develops GNExT platform to identify potential Alzheimer’s drug candidates
The Technical University of Munich has developed a web-based tool that connects genome-wide association study data with biological networks, helping researchers identify disease mechanisms and potential drug repurposing opportunities